Thank you, Carolyn. I appreciate it very much.
I am also very encouraged by what we've just heard from both witnesses on the degree of research and the attention being paid by both the Public Health Agency of Canada and Institute of Infection and Immunology.
I'll be very brief, Mr. Chair, and maybe, Carolyn, you'll still have some time left if you have a question.
To you, Mr. Sternthal, when was the action plan that's referred to in your evidence put in place? I gather that we're still at a preliminary stage, and I'm simply wondering when we started.